Aarey Drugs and Pharmaceuticals Q3 Result 2024: Date and Time, Share Price and Target

News: Aarey Drugs and Pharmaceuticals, a prominent player in the biotechnology and drugs sector, recently released its Q3 2024 results. In this article, we’ll delve into the essential details, including the date and time of the announcement, share price movements, and the company’s performance targets.

Date and Time of Q3 Results

The eagerly awaited Q3 results for Aarey Drugs and Pharmaceuticals are scheduled to be unveiled on January 20, 2024. Investors, analysts, and stakeholders are keenly anticipating this announcement to gain insights into the company’s financial health.

Share Price Movement

As of the latest update, Aarey Drugs & Pharmaceuticals’ share price stands at ₹54.30 on the BSE (Bombay Stock Exchange) and ₹54.30 on the NSE (National Stock Exchange) . The stock has experienced a -2.51% change recently.

Subscribe to Sarkari Result to stay informed. Get the latest celebrity news and detailed movie reviews in real-time. Keep up with the constantly changing world of entertainment with Sarkari Exam.

Financial Snapshot

Here’s a snapshot of the company’s financial performance for Q3 2024:

• Total Revenue: ₹62.47 crores
• Gross Profit: ₹3.85 crores
• Operating Income: ₹0.98 crores
• Net Income After Taxes: ₹0.49 crores
• Diluted Earnings Per Share (EPS): ₹0.19

Targets and Outlook

Aarey Drugs and Pharmaceuticals aims to continue its growth trajectory by focusing on innovation, research, and market expansion. Investors should keep an eye on the company’s strategic moves and management commentary during the results announcement.

About Aarey Drugs & Pharmaceuticals Limited

Aarey Drugs & Pharmaceuticals Limited, incorporated in 1990, is a listed public company based in Thane, Maharashtra, India. Let’s explore more about this pharmaceutical player:

Business Focus:

• Aarey Drugs and Pharmaceuticals is engaged in the business of manufacturing active pharmaceutical ingredients (APIs), intermediates, and specialty chemicals.

• The company also trades in industrial solvents and chemicals.

Product Portfolio:

• APIs and Intermediates: Aarey Drugs produces APIs and intermediates used in pharmaceutical formulations.

• Specialty Chemicals: The company offers a wide array of specialty chemicals catering to various industries.

• Industrial Solvents: Aarey Drugs supplies industrial solvents to different sectors globally.

Stock Performance:

• Aarey Drugs & Pharmaceuticals Ltd. is involved in bulk drug manufacturing.

• The company manufactures active pharmaceutical ingredients, intermediates, and specialty chemicals.

• It also trades in industrial solvents and chemicals .

Vision and Mission:

• Vision: To become a leading global manufacturer of specialty chemicals and API intermediates by 2020.

• Mission: To grow towards becoming a transnational Pharma Company through continuous research and innovative technology.

Leadership:

• Mr. Mihir Ghatalia, the director of Aarey Drugs & Pharmaceuticals, holds a B.S. in Chemical Engineering from Virginia Polytechnic Institute & State University in the United States.

Investors and stakeholders are advised to stay informed about Aarey Drugs and Pharmaceuticals’ Q3 results. The company’s financial performance and outlook will play a crucial role in shaping its future prospects.

Disclaimer: Please note that all content and tools on this website are provided for your convenience and are offered “as is” without warranties. The information provided, including any tool-generated output, is for informational purposes only and should not be considered investment advice or guarantees. Exercise caution, seek professional advice, and make independent judgments before acting on any information found on this site.